Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


New Therapy for Heart Attack Patients Approved by FDA for Clinical Trials 

 

 

New Therapy for Heart Attack Patients Approved by FDA for Clinical Trials

July 9, 2012 - (CIRM) - "The therapy, which will be taken forward by Los Angeles-based biotechnology company Capricor, uses Cardiosphere Derived Cells (CDCs) to reduce scarring and repair the damage caused to heart muscle by a heart attack. Funding for research that contributed to the potential therapy came from California’s stem cell agency, the California Institute for Regenerative Medicine (CIRM)."  Read Full Article

 

Posted on 16-Jul-12 by Toto, Brent
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: